S2E7 - Infliximab, Antipsychotic Duration, and Dimensional Diagnosis
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
The seventh episode of season two of The Psych Review finds Dave looking internationally (again) at the use of infliximab in the treatment of bipolar depression, see's Shakira explore how...
mostra di piùThe articles covered in this month's episode are:
- Dave: McIntyre, R. S., Subramaniapillai, M., Lee, Y., Pan, Z., Carmona, N. E., Shekotikhina, M., ... & Miller, S. (2019). Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial. JAMA psychiatry.
- Shakira: Bendall, S. (2019). Costs versus benefits and impact on life goals should be part of communication around anti-psychotic treatment duration in schizophrenia. Australian & New Zealand Journal of Psychiatry, 53(8), 811–812. https://doi.org/10.1177/0004867419860905
- Mazz: Irwin, L. and Mahli, S. G. (2019). Borderline personality disorder and ICD-11: A chance for change. Australian and New Zealand Journal of Psychiatry, 53(7) pages 698-700.
The Psych Review was brought to you by Call to Mind, a new telepsychiatry service that you can learn more about at www.calltomind.com.au. The original music in our podcast was provided by the very talented John Badgery, and our logo was designed by the creative genius of Naz.
Informazioni
Autore | The Psych Review |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company